Structure Therapeutics logo

Structure Therapeutics Share Price Today

(NASDAQ: GPCR)

Structure Therapeutics share price is $23.73 & ₹2,027.91 as on 26 Apr 2025, 2.30 'hrs' IST

$23.73

0.08

(0.34%)

Live

View live Structure Therapeutics share price in Dollar and Rupees. Guide to invest in Structure Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Structure Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Structure Therapeutics share price movements

  • Today's Low: $23.23
    Today's High: $24.10

    Day's Volatility :3.61%

  • 52 Weeks Low: $13.22
    52 Weeks High: $62.74

    52 Weeks Volatility :78.93%

Structure Therapeutics (GPCR) Returns

PeriodStructure Therapeutics, Inc.Index (Russel 2000)
3 Months
-16.19%
0.0%
6 Months
-37.08%
0.0%
1 Year
-39.33%
0.0%
3 Years
-9.04%
-9.5%

Structure Therapeutics (GPCR) Key Statistics

in dollars & INR

Previous Close
$23.65
Open
$23.5
Today's High
$24.1006
Today's Low
$23.2315
Market Capitalization
$1.3B
Today's Volume
$728.4K
52 Week High
$62.74
52 Week Low
$13.22
Revenue TTM
$0.0
EBITDA
$-157.2M
Earnings Per Share (EPS)
$-2.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-18.6%

How to invest in Structure Therapeutics Stock (GPCR) from India?

It is very easy for Indian residents to invest directly in Structure Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Structure Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Structure Therapeutics or GPCR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Structure Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Structure Therapeutics shares which would translate to 0.036 fractional shares of Structure Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Structure Therapeutics, in just a few clicks!

Returns in Structure Therapeutics (GPCR) for Indian investors in Rupees

The Structure Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Structure Therapeutics investment value today

Current value as on today

₹63,453

Returns

₹36,547

(-36.55%)

Returns from Structure Therapeutics Stock

₹39,123 (-39.12%)

Dollar Returns

₹2,575 (+2.58%)

Indian investors sentiment towards Structure Therapeutics (GPCR)

21.28%

Period: Mar 26, 2025 to Apr 25, 2025. Change in 30 Days versus previous period

Investment in Structure Therapeutics Shares from India has grown by 21.28% over the past 30 days, indicating increased transactional activity.

33%

Period: Mar 26, 2025 to Apr 25, 2025. Change in 30 Days versus previous period

Search interest for Structure Therapeutics Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Structure Therapeutics

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Structure Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Structure Therapeutics Stock (GPCR)

What analysts predicted

Upside of 237.77%

Target:

$80.15

Current:

$23.73

Insights on Structure Therapeutics Stock (Ticker Symbol: GPCR)

  • Price Movement

    In the last 1 month, GPCR stock has moved up by 16.3%
  • GPCR vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 72.4% return, outperforming this stock by 111.7%

Structure Therapeutics Technicals Summary

Sell

Neutral

Buy

Structure Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Structure Therapeutics (GPCR) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Structure Therapeutics, Inc. logo
18.25%
-37.08%
-39.33%
-9.04%
-9.04%
Regeneron Pharmaceuticals, Inc. logo
-6.31%
-35.72%
-32.66%
-11.12%
9.54%
Beone Medicines Ltd logo
2.09%
20.37%
72.43%
67.9%
55.25%
Vertex Pharmaceuticals Incorporated logo
-1.56%
3.09%
23.83%
83.97%
83.41%
Alnylam Pharmaceuticals, Inc. logo
-9.88%
-14.83%
68.82%
56.52%
70.01%

Structure Therapeutics Dividend announcements

  • Structure Therapeutics Earnings

    Structure Therapeutics’s price-to-earnings ratio stands at None

About Structure Therapeutics

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671, which is in preclinical trial to treat obesity; ANPA-0073, an oral small molecule agonist targeting the apelin, which is phase 2 ready for selective weight loss or muscle-sparing weight loss; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Organization
Structure Therapeutics
Employees
163
CEO
Dr. Raymond C. Stevens Ph.D.
Industry
Healthcare

Management People of Structure Therapeutics

NameTitle
Dr. Raymond C. Stevens Ph.D.
CEO & Director
Mr. Jun S. Yoon
Co- Founder, CFO & Secretary
Dr. Yingli Ma Ph.D.
Chief Technology Officer
Dr. Xichen Lin Ph.D.
Chief Scientific Officer
Mr. Tony Peng
Senior Vice President of Legal
Mr. Bob Gatmaitan
Senior Vice President of People
Dr. Hui Lei Ph.D.
Senior Vice President of Chemistry
Dr. Fang Zhang Ph.D.
Executive VP & Head of Biology
Ms. Lani Ibarra
Senior Vice President of Clinical Development Operations
Dr. Xinglong Jiang Ph.D.
Senior Vice President of Preclinical Development

Important FAQs about investing in GPCR Stock from India :

What is Structure Therapeutics share price today?

Structure Therapeutics share price today stands at $23.73, Open: $23.21 ; Previous Close: $23.65 ; High: $24.10 ; Low: $23.23 ; 52 Week High: $62.74 ; 52 Week Low: $13.22.

The stock opens at $23.21, after a previous close of $23.65. The stock reached a daily high of $24.10 and a low of $23.23, with a 52-week high of $62.74 and a 52-week low of $13.22.

Can Indians buy Structure Therapeutics shares?

Yes, Indians can invest in the Structure Therapeutics (GPCR) from India.

With INDmoney, you can buy Structure Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Structure Therapeutics at zero transaction cost.

How can I buy Structure Therapeutics shares from India?

It is very easy to buy Structure Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Structure Therapeutics (GPCR) be purchased?

Yes, you can buy fractional shares of Structure Therapeutics with INDmoney app.

What are the documents required to start investing in Structure Therapeutics stocks?

To start investing in Structure Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Structure Therapeutics Stock (GPCR)?

Today’s highest price of Structure Therapeutics (GPCR) is $24.10.

Today’s lowest price of Structure Therapeutics (GPCR) is $23.23.

What is today's market capitalisation of Structure Therapeutics?

Today's market capitalisation of Structure Therapeutics GPCR is 1.3B

What is the 52 Week High and Low Range of Structure Therapeutics Stock (GPCR)?

  • 52 Week High

    $62.74

  • 52 Week Low

    $13.22

What are the historical returns of Structure Therapeutics (GPCR)?

  • 1 Month Returns

    18.25%

  • 3 Months Returns

    -37.08%

  • 1 Year Returns

    -39.33%

  • 5 Years Returns

    -9.04%

Who is the Chief Executive Officer (CEO) of Structure Therapeutics ?

Dr. Raymond C. Stevens Ph.D. is the current Chief Executive Officer (CEO) of Structure Therapeutics.

Discover More